Vbi Vaccines Stock Price Prediction
| VBIV Stock | USD 0.59 0.02 3.28% |
Oversold Vs Overbought
49
Oversold | Overbought |
VBI Vaccines stock price prediction is an act of determining the future value of VBI Vaccines shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of VBI Vaccines' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of VBI Vaccines and does not consider all of the tangible or intangible factors available from VBI Vaccines' fundamental data. We analyze noise-free headlines and recent hype associated with VBI Vaccines, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting VBI Vaccines' stock price prediction:EPS Estimate Next Quarter (0.47) | EPS Estimate Current Year (1.39) | EPS Estimate Next Year (0.51) | Wall Street Target Price 5 | EPS Estimate Current Quarter (0.53) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of VBI Vaccines based on different types of headlines from major news networks to social media. The VBI stock price prediction module provides an analysis of price elasticity to changes in media outlook on VBI Vaccines over a specific investment horizon. Using VBI Vaccines hype-based prediction, you can estimate the value of VBI Vaccines from the perspective of VBI Vaccines response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards VBI Vaccines using VBI Vaccines' stock options and short interest. It helps to benchmark the overall future attitude of investors towards VBI using crowd psychology based on the activity and movement of VBI Vaccines' stock price.
VBI Vaccines Implied Volatility | 0.0 |
VBI Vaccines' implied volatility exposes the market's sentiment of VBI Vaccines stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if VBI Vaccines' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that VBI Vaccines stock will not fluctuate a lot when VBI Vaccines' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in VBI Vaccines. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in VBI Vaccines to buy its stock at a price that has no basis in reality. In that case, they are not buying VBI because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
VBI Vaccines after-hype prediction price | USD 0.59 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
VBI |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VBI Vaccines' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
VBI Vaccines After-Hype Price Prediction Density Analysis
As far as predicting the price of VBI Vaccines at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in VBI Vaccines or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of VBI Vaccines, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
VBI Vaccines Estimiated After-Hype Price Volatility
In the context of predicting VBI Vaccines' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on VBI Vaccines' historical news coverage. VBI Vaccines' after-hype downside and upside margins for the prediction period are 0.03 and 7.37, respectively. We have considered VBI Vaccines' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
VBI Vaccines is extremely dangerous at this time. Analysis and calculation of next after-hype price of VBI Vaccines is based on 3 months time horizon.
VBI Vaccines Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as VBI Vaccines is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading VBI Vaccines backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with VBI Vaccines, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.10 | 6.84 | 0.00 | 0.01 | 8 Events / Month | 11 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.59 | 0.59 | 0.00 |
|
VBI Vaccines Hype Timeline
VBI Vaccines is at this time traded for 0.59. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. VBI is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.1%. %. The volatility of related hype on VBI Vaccines is about 5211.43%, with the expected price after the next announcement by competition of 0.58. The company has Price to Book (P/B) ratio of 0.82. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. VBI Vaccines recorded a loss per share of 6.03. The entity last dividend was issued on the 28th of December 2012. The firm had 1:30 split on the 12th of April 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out VBI Vaccines Basic Forecasting Models to cross-verify your projections.VBI Vaccines Related Hype Analysis
Having access to credible news sources related to VBI Vaccines' direct competition is more important than ever and may enhance your ability to predict VBI Vaccines' future price movements. Getting to know how VBI Vaccines' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how VBI Vaccines may potentially react to the hype associated with one of its peers.
VBI Vaccines Additional Predictive Modules
Most predictive techniques to examine VBI price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for VBI using various technical indicators. When you analyze VBI charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About VBI Vaccines Predictive Indicators
The successful prediction of VBI Vaccines stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as VBI Vaccines, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of VBI Vaccines based on analysis of VBI Vaccines hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to VBI Vaccines's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to VBI Vaccines's related companies. | 2021 | 2023 | 2024 (projected) | Days Sales Outstanding | 4.63 | 53.31 | 50.64 | PTB Ratio | 4.15 | 1.22 | 0.66 |
Story Coverage note for VBI Vaccines
The number of cover stories for VBI Vaccines depends on current market conditions and VBI Vaccines' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that VBI Vaccines is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about VBI Vaccines' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
VBI Vaccines Short Properties
VBI Vaccines' future price predictability will typically decrease when VBI Vaccines' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of VBI Vaccines often depends not only on the future outlook of the potential VBI Vaccines' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. VBI Vaccines' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.6 M | |
| Cash And Short Term Investments | 23.7 M |
Check out VBI Vaccines Basic Forecasting Models to cross-verify your projections. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.03) | Revenue Per Share 0.558 | Quarterly Revenue Growth 1.911 | Return On Assets (0.29) | Return On Equity (2.59) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.